select semaglutide Trial: reduces the risk of MACE by 20% in people with overweight or obesity, pre-existing CVD, and no diabetes. Average weight loss of -9.4% at 51 months Two new GLP-1 CVOTs outlined

Matsumoto M, Hikosaka O

Provide your doctor with the name, dose, and duration of each antidepressant, as well as any other psychiatric medications (mood stabilizers, anti-anxiety agents)

Because your GLP-1 receptors are already fully adapted from tirzepatide use, most providers skip the 0.25 mg initiation dose

10.1530/JOE-23-0342 J Endocrinol

"By bringing the API manufacturing domestic, we can control far more of the process end to end, giving us advantages in quality and purity and reliability and ultimately, in brand trust that I think will be incredibly difficult for others to match and I think increasingly important as these treatments and therapeutics become more mass market," Dudum said during the call